EXEL
Exelixis Inc

12,215
Mkt Cap
$11.52B
Volume
8,700.00
52W High
$49.62
52W Low
$32.38
PE Ratio
18.09
EXEL Fundamentals
Price
$42.50
Prev Close
$42.98
Open
$43.27
50D MA
$43.62
Beta
0.45
Avg. Volume
2.5M
EPS (Annual)
$1.76
P/B
5.33
Rev/Employee
$1.89M
$9,164.16
Loading...
Loading...
Exelixis, Inc. operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic. The company was founded by Stelios Papadopoulos on November 15, 1994, and is headquartered in Alameda, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
1,147

Frequently Asked Questions

What is Market Cap of Exelixis Inc?
What is the 52-week high for Exelixis Inc?
What is the 52-week low for Exelixis Inc?
What is Exelixis Inc stock price today?
What was Exelixis Inc stock price yesterday?
What is the PE ratio of Exelixis Inc?
What is the Price-to-Book ratio of Exelixis Inc?
What is the 50-day moving average of Exelixis Inc?
How many employees does Exelixis Inc have?

Latest EXEL News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.